Eli Lilly Message Board - Msg: 33343720

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly

LLY 884.54

+2.9%

Apr 25 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Moonray	6/1/2021 9:20:34 PM
	of 634

Eli Lilly gets Indian emergency use nod for Covid-19 antibody drug combination The company said it is in talks with the Indian government and regulatory authorities to donate the drugs to help speed up access and provide more treatment options for Covid-19 Eli Lilly and Co's antibody drug combination has received an emergency use approval in India for the treatment of mild-to-moderate Covid-19, bolstering the country's arsenal of medicines to tackle a devastating second wave of the pandemic. A combination of the U.S. drugmaker's monoclonal antibodies bamlanivimab and etesevimab has been given approval for restricted use in emergency situations in hospital settings in adults, the company's Indian unit said in an emailed statement. More at: kathmandupost.com o~~~ O

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next